{
  "id": 680390,
  "title": "Eli Lilly targets alleged black market sales of its experimental GLP-1 drug",
  "url": "https://urgent.news/2026/08/12/eli-lilly-targets-alleged-black-market-sales-of-its-experimental-glp",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-12T16:19:16.000Z",
  "source": {
    "name": "The Hill",
    "slug": "the-hill",
    "url": "https://thehill.com/policy/healthcare/6025205-lilly-targets-illegal-weight-loss-drugs/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Eli Lilly is suing six entities that it alleges are selling black market versions of its experimental weight-loss drug retatrutide. Lilly's lawsuits target U.S. entities selling illegal retatrutide products, including compounding pharmacies, medical spas and online sellers that sell retatrutide as a weight-loss \"hack.\" Those entities falsely claim their drugs are for “research-use only” when...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Fortune",
        "title": "Lilly escalates its fight against black market weight-loss shots",
        "url": "https://urgent.news/2026/08/12/lilly-escalates-its-fight-against-black-market-weight-loss-shots",
        "published": "2026-08-12T14:59:58.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}